• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型强效聚(ADP-核糖)合成酶抑制剂PJ34对心肌的保护作用

Myocardial protection by PJ34, a novel potent poly (ADP-ribose) synthetase inhibitor.

作者信息

Faro Renato, Toyoda Yoshiya, McCully James D, Jagtap Prakash, Szabo Eva, Virag Laszlo, Bianchi Cesario, Levitsky Sidney, Szabo Csaba, Sellke Frank W

机构信息

Division of Cardiothoracic Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA.

出版信息

Ann Thorac Surg. 2002 Feb;73(2):575-81. doi: 10.1016/s0003-4975(01)03329-x.

DOI:10.1016/s0003-4975(01)03329-x
PMID:11845877
Abstract

BACKGROUND

The activation of poly (ADP-ribose) synthetase plays an important role in the pathogenesis leading to myocardial ischemia-reperfusion injury. The aim of this study was to determine if a novel potent inhibitor of poly (ADP-ribose) synthetase, PJ34, provides myocardial protection.

METHODS

Pigs were subjected to 60 minutes of regional ischemia followed by 180 minutes of reperfusion. Ten mg/kg of PJ34 (PJ34; n = 6) was administrated intravenously (treated group) from 15 to 5 minutes before reperfusion followed by 3 mg/kg/hour of PJ34 from 5 minutes before reperfusion to the end of 180 minutes reperfusion. Control pigs (n = 7) received vehicle only. Arterial and left ventricular pressure and coronary flow were monitored.

RESULTS

The PJ34 showed significant reduction on infarct size (37.5%+/-4.5% and 50.5%+/-4.8% of the area at risk) for PJ34 and control pigs groups, respectively, (p < 0.05). Significant reduction in postsystolic shortening, as well as improvement on segment shortening, and positive first derivative of pressure over time (+dP/dt) maximum were also observed in PJ34 versus control pigs (p < 0.05).

CONCLUSIONS

Our results suggest that PJ34 provides cardioprotection by decreasing myocardial infarct size and enhancing postischemic regional and global functional recovery.

摘要

背景

聚(ADP - 核糖)合成酶的激活在导致心肌缺血 - 再灌注损伤的发病机制中起重要作用。本研究的目的是确定新型强效聚(ADP - 核糖)合成酶抑制剂PJ34是否能提供心肌保护作用。

方法

对猪进行60分钟的局部缺血,随后进行180分钟的再灌注。在再灌注前15分钟至5分钟静脉注射10mg/kg的PJ34(PJ34组;n = 6),然后在再灌注前5分钟至再灌注180分钟结束时以3mg/kg/小时的剂量静脉注射PJ34。对照猪(n = 7)仅接受赋形剂。监测动脉压、左心室压力和冠状动脉血流量。

结果

PJ34组和对照组猪的梗死面积分别显著减小(分别为危险区域面积的37.5%±4.5%和50.5%±4.8%)(p < 0.05)。与对照猪相比,PJ34组还观察到收缩后缩短显著减少,节段缩短改善,以及压力随时间的一阶导数最大值(+dP/dt)增加(p < 0.05)。

结论

我们的结果表明,PJ34通过减小心肌梗死面积和增强缺血后局部和整体功能恢复来提供心脏保护作用。

相似文献

1
Myocardial protection by PJ34, a novel potent poly (ADP-ribose) synthetase inhibitor.新型强效聚(ADP-核糖)合成酶抑制剂PJ34对心肌的保护作用
Ann Thorac Surg. 2002 Feb;73(2):575-81. doi: 10.1016/s0003-4975(01)03329-x.
2
Poly(ADP-ribose) polymerase inhibition improves postischemic myocardial function after cardioplegia-cardiopulmonary bypass.聚(ADP - 核糖)聚合酶抑制可改善心脏停搏 - 体外循环后缺血性心肌功能。
J Am Coll Surg. 2003 Aug;197(2):270-7. doi: 10.1016/S1072-7515(03)00538-6.
3
Poly-ADP-ribose polymerase inhibition protects against myocardial and endothelial reperfusion injury after hypothermic cardiac arrest.多聚 ADP - 核糖聚合酶抑制可预防低温心脏骤停后的心肌和内皮再灌注损伤。
J Thorac Cardiovasc Surg. 2003 Sep;126(3):651-8. doi: 10.1016/s0022-5223(02)73235-2.
4
Poly(ADP-Ribose) polymerase inhibition reduces reperfusion injury after heart transplantation.聚(ADP - 核糖)聚合酶抑制可减轻心脏移植后的再灌注损伤。
Circ Res. 2002 Jan 11;90(1):100-6. doi: 10.1161/hh0102.102657.
5
Reduction of myocardial reperfusion injury by an inhibitor of poly (ADP-ribose) synthetase in the pig.聚(ADP - 核糖)合成酶抑制剂减轻猪心肌再灌注损伤
Eur J Pharmacol. 1998 Oct 23;359(2-3):143-50. doi: 10.1016/s0014-2999(98)00638-4.
6
Aminoguanidine inhibits inducible NOS and reverses cardiac dysfunction late after ischemia and reperfusion--implications for iNOS-mediated myocardial stunning.氨基胍可抑制诱导型一氧化氮合酶,并逆转缺血再灌注晚期的心脏功能障碍——对诱导型一氧化氮合酶介导的心肌顿抑的影响。
Thorac Cardiovasc Surg. 1999 Jun;47(3):137-43. doi: 10.1055/s-2007-1013128.
7
Novel phenanthridinone inhibitors of poly (adenosine 5'-diphosphate-ribose) synthetase: potent cytoprotective and antishock agents.新型聚(腺苷5'-二磷酸核糖)合成酶菲啶酮抑制剂:强效细胞保护剂和抗休克剂。
Crit Care Med. 2002 May;30(5):1071-82. doi: 10.1097/00003246-200205000-00019.
8
Protective effect of a novel, potent inhibitor of poly(adenosine 5'-diphosphate-ribose) synthetase in a porcine model of severe bacterial sepsis.一种新型强效聚(腺苷5'-二磷酸核糖)合成酶抑制剂在猪严重细菌性败血症模型中的保护作用。
Crit Care Med. 2002 May;30(5):974-80. doi: 10.1097/00003246-200205000-00004.
9
PJ34, a poly-ADP-ribose polymerase inhibitor, modulates renal injury after thoracic aortic ischemia/reperfusion.
Surgery. 2005 Aug;138(2):368-74. doi: 10.1016/j.surg.2005.06.004.
10
A novel peroxynitrite decomposer catalyst (FP-15) reduces myocardial infarct size in an in vivo peroxynitrite decomposer and acute ischemia-reperfusion in pigs.一种新型过氧亚硝酸盐分解催化剂(FP-15)可减小猪体内过氧亚硝酸盐分解及急性缺血再灌注模型中的心肌梗死面积。
Ann Thorac Surg. 2002 Oct;74(4):1201-7. doi: 10.1016/s0003-4975(02)03953-x.

引用本文的文献

1
PARP1 Activation Induces HMGB1 Secretion Promoting Intestinal Inflammation in Mice and Human Intestinal Organoids.PARP1 激活诱导 HMGB1 分泌促进小鼠和人肠类器官中的肠道炎症。
Int J Mol Sci. 2023 Apr 12;24(8):7096. doi: 10.3390/ijms24087096.
2
Inhibition of GSDMD Activates Poly(ADP-ribosyl)ation and Promotes Myocardial Ischemia-Reperfusion Injury.GSDMD 抑制物激活聚(ADP-核糖)化并促进心肌缺血再灌注损伤。
Oxid Med Cell Longev. 2022 Jun 24;2022:1115749. doi: 10.1155/2022/1115749. eCollection 2022.
3
Role of Oxidative DNA Damage and Repair in Atrial Fibrillation and Ischemic Heart Disease.
氧化DNA损伤与修复在心房颤动和缺血性心脏病中的作用
Int J Mol Sci. 2021 Apr 7;22(8):3838. doi: 10.3390/ijms22083838.
4
Mitochondrial Protection by PARP Inhibition.PARP 抑制对线粒体的保护作用。
Int J Mol Sci. 2020 Apr 16;21(8):2767. doi: 10.3390/ijms21082767.
5
The potential of PARP inhibitors in neuro-oncology.PARP抑制剂在神经肿瘤学中的潜力。
CNS Oncol. 2012 Sep;1(1):85-97. doi: 10.2217/cns.12.13.
6
The Sound of Silence: RNAi in Poly (ADP-Ribose) Research.沉默之声:RNAi 在聚(ADP-核糖)研究中的作用。
Genes (Basel). 2012 Dec 6;3(4):779-805. doi: 10.3390/genes3040779.
7
Effect of nitric oxide on naphthoquinone toxicity in endothelial cells: role of bioenergetic dysfunction and poly (ADP-ribose) polymerase activation.一氧化氮对内皮细胞中萘醌毒性的影响:与生物能量功能障碍和多聚(ADP-核糖)聚合酶激活有关。
Biochemistry. 2013 Jun 25;52(25):4364-72. doi: 10.1021/bi400342t. Epub 2013 Jun 14.
8
Therapeutic applications of PARP inhibitors: anticancer therapy and beyond.PARP 抑制剂的治疗应用:抗癌治疗及其他。
Mol Aspects Med. 2013 Dec;34(6):1217-56. doi: 10.1016/j.mam.2013.01.006. Epub 2013 Jan 29.
9
Vincristine attenuates N-methyl-N'-nitro-N-nitrosoguanidine-induced poly-(ADP) ribose polymerase activity in cardiomyocytes.长春新碱可抑制 N-甲基-N'-硝基-N-亚硝胍诱导的心肌细胞多聚(ADP-核糖)聚合酶活性。
J Cardiovasc Pharmacol. 2010 Mar;55(3):219-26. doi: 10.1097/FJC.0b013e3181c87e6c.
10
Inhibition of the activity of poly (ADP-ribose) polymerase reduces heart ischaemia/reperfusion injury via suppressing JNK-mediated AIF translocation.抑制聚(ADP - 核糖)聚合酶的活性可通过抑制JNK介导的AIF易位来减轻心脏缺血/再灌注损伤。
J Cell Mol Med. 2008 Aug;12(4):1220-8. doi: 10.1111/j.1582-4934.2008.00183.x.